RELCOF PE (Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
Pill with imprint RELCOF PE is White, Capsule-shape and has been identified as Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg. It is supplied by Burel Pharmaceuticals, Inc.
RelCof PE is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. RelCof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RELCOF PE
Relcof PE
- Generic Name
- chlorpheniramine/methscopolamine/phenylephrine
- Imprint
- RELCOF PE
- Strength
- chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg
- Color
- White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 35573-0003 (Discontinued)
More about RelCof PE (chlorpheniramine / methscopolamine / phenylephrine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Drug class: upper respiratory combinations
Patient resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.